Twist Bioscience

Twist Bioscience R&D per Employee

The R&D Spending per Employee of Twist Bioscience (TWST) as of Oct 9, 2026 is 82,007.15 USD. In the previous year, R&D Spending per Employee was 92,800.82 USD — a change of -11.63% (lower).

R&D per Employee

82,007.15USD

YoY

-11.63%

Last updated:

R&D Spending per Employee of Twist Bioscience is 2025 82,007.15 USD. R&D Spending per Employee of Twist Bioscience was 2024 92,800.82 USD. It decreases by -11.63% lower compared to the previous year.

The Twist Bioscience R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
20,783.45 USD
Jan 1, 2019
36,448.42 USD
Jan 1, 2020
43,928.50 USD
Jan 1, 2021
70,553.63 USD
Jan 1, 2022
122,887.64 USD
Jan 1, 2023
109,186.93 USD
Jan 1, 2024
92,800.82 USD
Jan 1, 2025
82,007.15 USD
The Twist Bioscience R&D per Employee history
YEARR&D per EmployeeYoY
82,007.15USD-11.63%
92,800.82USD-15.01%
109,186.93USD-11.15%
122,887.64USD+74.18%
70,553.63USD+60.61%
43,928.50USD+20.52%
36,448.42USD+75.37%
20,783.45USD+6.15%
19,580.18USD+5.15%
18,621.04USD—
Access this data via the Eulerpool API

Twist Bioscience Stock analysis

What does Twist Bioscience do? Twist Bioscience Corp is a company specializing in the production and applications of synthetic DNA. It was founded in 2013 and is based in San Francisco, California, USA. The company utilizes proprietary technologies to cost-effectively produce high-quality and high-quantity synthetic DNA. The company operates in three business areas: DNA synthesis, biopharmaceuticals, and data storage. The DNA synthesis division is the core of the company and involves the production of synthetic DNA for applications in various industries, including medicine, agricultural science, biotechnology, plastic engineering, and others. The company manufactures customized DNA synthesis products tailored to the needs of its customers, allowing them to accelerate and optimize their research and development projects. Twist Bioscience has also developed a proprietary technology called "Twist Biosensor" that enables rapid and cost-effective analysis of genetic variations. The biopharmaceutical division focuses on the development of therapeutics and diagnostics based on synthetic DNA. Twist Bioscience develops antibodies and proteins that can be used in cancer and immunotherapy, as well as diagnostics. In the data storage field, Twist Bioscience develops solutions for storing large amounts of data on DNA. This technology utilizes the dense and stable structure of DNA to securely and reliably store data in the long term. Twist Bioscience's DNA synthesis products are utilized by researchers, companies, and public institutions in various industries. Customers value not only the wide product portfolio but also the high quality and precision of the products, as well as the speed of order processing. The company operates a number of manufacturing facilities near its customers in Europe and Asia to ensure fast and efficient delivery of its products. This allows Twist Bioscience to have a strong position in the global market. In recent years, the company has achieved significant milestones. In 2018, Twist Bioscience went public and raised a total of $70 million through its IPO. The company has also established partnerships with various other companies and institutions to develop new applications and products. Overall, Twist Bioscience is a growing company specializing in the production and applications of synthetic DNA. With its wide range of high-quality and customized DNA synthesis products, as well as its innovative solutions in the biopharmaceutical and data storage sectors, the company has established a strong market position. Twist Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Twist Bioscience stock

R&D Spending per Employee of Twist Bioscience is 82,007.15 USD in 2025.

R&D Spending per Employee of Twist Bioscience changed from 92,800.82 USD to 82,007.15 USD, representing a -11.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Twist Bioscience since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Twist Bioscience historically and in real time.

Access this data via the Eulerpool API

Workforce — Twist Bioscience

All Key Metrics — Twist Bioscience